Legit Online Viagra! Dead Rat, Boric Acid, Etc., Not Included.
Pfizer, the company best known for fighting online purchases of prescription drugs - especially Viagra, has decided on a new approach: setting up its...
Pfizer Integrates Daytime TV Spots, YouTube, Facebook, Twitter, Slideshare, & Blogs. Focus is Less...
Over the months I have reviewed several of Pfizer's digital and social media efforts and have said that the company is good at promoting...
The Adherence Problem: Are Patients Just Forgetful, or Are They Rebellious?
This is the adherence season for pharma industry conferences. This Monday and Tuesday was the 12th Annual Patient Adherence and Support Summit produced by...
Most Physicians Agree That DTC Advertising Leads to Inappropriate Prescribing — by OTHER Doctors,...
When the FDA announced it was moving a head with yet another study of direct-to-consumer (DTC) advertising, I said:
"Very few healthcare professionals are going...
Why Pharma Execs Fear to Follow on Twitter
There are no Big Pharma CEOs that I know of who actively and directly engage with their stakeholders -- investors, physicians, patients -- using...
Novartis Wines — er, Beers — and Dines Docs at Hooters!
The U.S. Justice Department announced yesterday that it has filed a second civil false claims lawsuit against Novartis Pharmaceuticals Corp. involving alleged kickbacks paid...
Your Aging Problem: Is It [LowT]? Take this Quiz and Find Out. Or Just...
Have you noticed a recent deterioration in your ability to play sports? Are you falling asleep after dinner?
Those are just two of the questions...
Sorry Charlie! Novo’s Race with Insulin “Chain E-mail” Sweepstakes Campaign is Spam
I once characterized a @Racewithinsulin Levemir branded tweet as "Sleazy Twitter Spam" (search Google on "race with insulin spam" and you'll find this post)....
Why Big Pharma Can’t Battle Big Bugs
A critical shortage of antibiotic drugs threatens to "derail efforts to fight the so called superbugs," according to a new report by the Infectious...
Fixing Pharma’s Reputation: IMHO, the Train Has Left the Station
In an "open letter" to PhRMA CEO, John Castellani, Forbes Blogger and former president of Pfizer Global Research, John LaMattina, offers several suggestions for...
